Plasma visfatin levels and gene expression in morbidly obese women with associated fatty liver disease-Reference-Cited by-同舟云学术

Plasma visfatin levels and gene expression in morbidly obese women with associated fatty liver disease

Published:2013-02 Issue:3 Volume:46 Page:202-208
ISSN:0009-9120
Container-title:Clinical Biochemistry
language:en
Short-container-title:Clinical Biochemistry

Author:

Auguet Teresa,Terra Ximena,Porras Jose Antonio,Orellana-Gavaldà Josep Maria,Martinez Salomé,Aguilar Carmen,Lucas Anna,Pellitero Silvia,Hernández Mercé,Del Castillo Daniel,Richart Cristóbal

Publisher

Elsevier BV

Subject

Clinical Biochemistry,General Medicine

Reference31 articles.

1. Visfatin, an adipocytokine with proinflammatory and immunomodulating properties;Moschen;J Immunol,2007

2. Cloning and characterization of the cDNA encoding a novel human pre-B-cell colony-enhancing factor;Samal;Mol Cell Biol,1994

3. Pre-B-cell colony-enhancing factor, whose expression is up-regulated in activated lymphocytes, is a nicotinamide phosphoribosyltransferase, a cytosolic enzyme involved in NAD biosynthesis;Rongvaux;Eur J Immunol,2002

4. Increased plasma visfatin concentrations in morbidly obese subjects are reduced after gastric banding;Haider;J Clin Endocrinol Metab,2006

5. Decreased visfatin after exercise training correlates with improved glucose tolerance;Haus;Med Sci Sports Exerc,2009

Cited by 56 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. NAD metabolic therapy in metabolic dysfunction-associated steatotic liver disease: Possible roles of gut microbiota;iScience;2024-03

2. Visfatin and Retinol Binding Protein-4 in Young-Onset Type 2 Diabetes Mellitus;Medicina;2023-07-09

3. Both prolonged high-fat diet consumption and calorie restriction boost hepatic NAD+ metabolism in mice;The Journal of Nutritional Biochemistry;2023-05

4. The relationship between NAFLD and retinol-binding protein 4 - an updated systematic review and meta-analysis;Lipids in Health and Disease;2023-01-21

5. Adipokines in Non-Alcoholic Fatty Liver Disease: Are We on the Road toward New Biomarkers and Therapeutic Targets?;Biology;2022-08-19